An authorized generic of Prevpac was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (amoxicillin, clarithromycin, and lansoprazole) is available.
Source: FDA, updated October 30, 2026
Generic name: amoxicillin, clarithromycin, and lansoprazole
Used for: H. pylori infection and ulcers
Ask for the cash price
Generic amoxicillin, clarithromycin, and lansoprazole
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as Prevpac, and the FDA requires it to work the same way.
Details for each option
Prevpac itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
An authorized generic of Prevpac was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (amoxicillin, clarithromycin, and lansoprazole) is available.
Source: FDA, updated October 30, 2026
One company sells a generic of Prevpac that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
Has dyes: D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
| Package | NDC |
|---|---|
| Carton of 14 | 57237-001-14 |
Inactive ingredients: acetone, hypromellose, isopropyl alcohol, magnesium carbonate, methacrylic acid and ethyl acrylate copolymer, polyethylene glycol 4000, polysorbate 80, starch, corn, talc, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, sodium lauryl sulfate, magnesium stearate, microcrystalline cellulose, silicon dioxide, croscarmellose sodium, hydroxypropyl cellulose, hypromellose 2910 (15 mpa.s), ferric oxide yellow, povidone k30, propylene glycol, sorbic acid, vanillin
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence
The components in PREVPAC (PREVACID, amoxicillin, and clarithromycin) are indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence (see CLINICAL STUDIES and DOSAGE AND ADMINISTRATION). To reduce the development of drug-resistant bacteria and maintain the effectiveness of PREVPAC and other antibacterial drugs, PREVPAC should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or
modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Source: the FDA label for Prevpac (Takeda Pharms Usa), June 7, 2018. Full label from the FDA (PDF)
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/prevpac/